Related Experiment Video
Updated: May 29, 2026

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
Published on: June 28, 2019
Assessment of red cell distribution width (RDW) in patients with coronary artery ectasia
Orhan Dogdu1, Fatih Koc, Nihat Kalay
1Department of Cardiology, Erciyes University School of Medicine, Kayseri, Turkey.
Insights
Red cell distribution width (RDW) is elevated in patients with coronary artery ectasia (CAE). This simple blood test may serve as a reliable marker for diagnosing CAE.
Area of Science:
- Cardiology
- Hematology
Background:
- Coronary artery ectasia (CAE) involves abnormal coronary artery dilation.
- Red cell distribution width (RDW) quantifies red blood cell size heterogeneity.
Purpose of the Study:
- To investigate red cell distribution width (RDW) levels in patients diagnosed with coronary artery ectasia (CAE).
Main Methods:
- The study included 54 patients with CAE and 40 controls with normal coronary arteries.
- Red cell distribution width (RDW) was measured using automated complete blood count on admission.
Main Results:
- Patients with coronary artery ectasia (CAE) exhibited significantly higher red cell distribution width (RDW) compared to controls (P < .001).
- High-sensitive C-reactive protein (hs-CRP) levels were also significantly elevated in the CAE group versus controls (P < .001).
Conclusions:
- Red cell distribution width (RDW) and hs-CRP levels are significantly higher in patients with coronary artery ectasia (CAE).
- RDW presents a reliable, simple, and inexpensive biomarker for identifying patients with coronary artery ectasia (CAE).
Objectives:
Coronary artery ectasia (CAE) is characterized by an abnormal dilatation of the coronary arteries. Red cell distribution width (RDW) is a measure of heterogeneity in the size of red blood cell. In this study, we aimed to investigate RDW levels in patients with CAE.
Methods:
The study population included 54 patients with CAE (28 males; mean age, 59 ± 12) and 40 individuals comprising the control group who had normal coronary arteries (17 males; mean age, 56 ± 10). Admission RDW was measured as part of the automated complete blood count.
Results:
The RDW was significantly higher in the CAE group than the control (P < .001). Also, high-sensitive C-reactive protein (hs-CRP) levels in patients with CAE were significantly higher as compared with controls (P < .001).
Conclusion:
This study demonstrates that RDW and hs-CRP were higher in the CAE group compared with the control group. These results show that RDW is a reliable, simple, and inexpensive marker for patients with CAE.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease IV: Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
